Search all medical codes

Injection, ranibizumab, 0.1 mg

HCPCS code

Injection, Ranibizumab, 0.1 mg (J2778)

Name of the Procedure:

  • Common Name: Eye Injection
  • Technical/Medical Term: Injection of Ranibizumab

Summary

Injection of ranibizumab is a procedure where a small amount of medication is injected directly into the eye. It is designed to treat certain eye conditions that can lead to vision loss.

Purpose

  • Conditions Addressed: Age-related macular degeneration (AMD), diabetic retinopathy, retinal vein occlusion
  • Goals/Outcomes: Reduce vision loss, improve vision by decreasing swelling and preventing the formation of abnormal blood vessels in the retina.

Indications

  • Evidence of wet age-related macular degeneration
  • Diabetic retinopathy causing macular edema
  • Retinal vein occlusion leading to macular edema
  • Patients experiencing significant vision loss due to these conditions

Preparation

  • Pre-procedure Instructions: No eating or drinking restrictions typically required unless otherwise instructed by your physician. Discontinue certain blood-thinning medications if advised by your doctor.
  • Assessments: Eye examination and possibly imaging tests like OCT (Optical Coherence Tomography) to assess the retina.

Procedure Description

  1. Anesthesia: Numbing drops are applied to the eye to prevent pain.
  2. Sterilization: The area around the eye is cleaned with an antiseptic solution to reduce infection risk.
  3. Injection: Using a fine needle, ranibizumab is injected into the vitreous humor (the gel-like substance inside the eye).
  4. Post-Injection: The eye may be rinsed, and an antibiotic drop may be applied to prevent infection.

Duration

  • The actual injection part of the procedure typically takes just a few minutes.
  • The entire process, including prep and post-injection care, usually takes 15-30 minutes.

Setting

  • The procedure is usually performed in an outpatient clinic or a specialized eye center.

Personnel

  • Healthcare Professionals Involved: Ophthalmologist (eye doctor), often assisted by a nurse or medical assistant.

Risks and Complications

  • Common Risks: Mild pain, redness, and irritation at the injection site, floaters in vision.
  • Rare Risks: Eye infection (endophthalmitis), increased intraocular pressure, retinal detachment, cataract formation.
  • Management: Most complications are managed with medication or additional treatments. Severe complications like infection require immediate medical attention.

Benefits

  • Expected Benefits: Improvement in vision, slowing or halting progression of vision loss.
  • Realization of Benefits: Some patients notice improvements within days to weeks, though it may take longer for others.

Recovery

  • Post-Procedure Care: Use prescribed antibiotic eye drops as instructed. Avoid getting water in the eye for a few days.
  • Recovery Time: Usually minimal, patients can often resume normal activities within a day, but it's recommended to avoid strenuous activity for a short period.
  • Follow-up: Regular follow-up appointments will be necessary to monitor the eye condition and determine if additional injections are needed.

Alternatives

  • Other Treatments: Alternative medications (like aflibercept or bevacizumab), laser therapies, photodynamic therapy.
  • Pros and Cons: Other medications and treatments may have different efficacy, risks, and cost profiles; it's important to discuss with your doctor to determine the best option for your condition.

Patient Experience

  • During the Procedure: Some pressure or discomfort might be felt during the injection, but it should not be painful due to the numbing drops.
  • After the Procedure: Mild discomfort or a gritty feeling in the eye, which usually resolves within a day. Vision might be blurry immediately after the injection, but this typically improves. Pain management usually involves OTC pain relievers if necessary.

Medical Policies and Guidelines for Injection, ranibizumab, 0.1 mg

Related policies from health plans

Similar Codes